Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 10Unknown 6Recruiting 5Not yet recruiting 3Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Melanoma 1Malignant Female Reproductive System Neoplasm 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Carboplatin 127Cisplatin 125Drug Therapy 116Bevacizumab 102Capecitabine 100Oxaliplatin 99Radiotherapy 97Gemcitabine 87tislelizumab 86Paclitaxel 86Cyclophosphamide 85pembrolizumab 77Specimen Handling 77toripalimab 70Magnetic Resonance Spectroscopy 63Injections 63Fluorouracil 63sintilimab 58Surgical Procedures, Operative 58anlotinib 53Docetaxel 52130-nm albumin-bound paclitaxel 51fludarabine 47Standard of Care 45Pemetrexed 45Immune Checkpoint Inhibitors 45Blood Specimen Collection 43venetoclax 42Leucovorin 42lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Rehabilitation × Clear all
NCT07608445 2026-05-27

Physiatry-Led Cancer Prehabilitation During Neoadjuvant Systemic Therapy to Improve Function in Stage III-IVA Gynecologic Cancer Patients

City of Hope Medical Center

Phase NA Not yet recruiting
25 enrolled

Malignant Female Reproductive System Neoplasm

NCT07320222 2026-01-06

CARE-Melanoma

McMaster University

Phase 1 Not yet recruiting
30 enrolled
Dermatologic

Melanoma

NCT06881940 2025-03-18

CARPTOX-BC

Instituto Nacional de Cardiologia Ignacio Chavez

Phase NA Not yet recruiting
284 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡